Rockville-based Sanaria develops whole-parasite sporozoite vaccines designed to protect people against malaria, with a particular focus on Plasmodium falciparum. Its custom Clinical Manufacturing Facility is described as the only facility of its type in the world, producing regulated, cryopreserved vaccine materials and research reagents. Founded by physician-scientist Stephen L. Hoffman, the company also coordinates a global PfSPZ research consortium involving more than 85 institutions.
cGMP Compliant Manufacturing
Compliance program
NovavaxHeadquartered in Gaithersburg, Maryland, Novavax is a biotech company that develops vaccines and vaccine technologies, pairing protein-based nanoparticles with its proprietary Matrix-M® adjuvant. Its platform underpins marketed vaccines for COVID-19 and malaria, while the company continues in-house R&D and works with pharmaceutical, research and government partners to advance additional medicines. Novavax also conducts R&D and Matrix-M manufacturing in Uppsala, Sweden.GAITHERSBURG, MD
Advanced BioScience Laboratories (ABL), IncFrom its Rockville base, Advanced BioScience Laboratories (ABL) develops and manufactures viral products for vaccines, gene therapies, oncolytic therapies and immunotherapies as a contract development and manufacturing organization. ABL brings more than 60 years of experience working with industry, government and academic partners, including over 30 years focused on viral-vector development and GMP production. Its Rockville facility is ISO 9001 accredited for viral drug-substance and aseptically prepared drug-product manufacturing, and the company has translated more than 100 processes from the laboratory bench into GMP suites.POTOMAC, MD
Emergent BioSolutionsFounded in 1998 to supply the U.S. government with anthrax vaccine, Emergent BioSolutions develops and manufactures medical countermeasures and other protective products for biological threats and opioid overdose emergencies. The company also operates as a strategic manufacturing partner, using specialized containment capabilities across four North American facilities to help biopharma companies, governments and nonprofits develop and make complex biological products. Its commercial portfolio includes NARCAN® Nasal Spray alongside preparedness products for threats such as anthrax, smallpox and botulism.ROCKVILLE, MD